• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Nuclear Medicine Imaging Equipment - Global Strategic Business Report Product Image

Nuclear Medicine Imaging Equipment - Global Strategic Business Report

  • ID: 338509
  • July 2014
  • Region: Global
  • 247 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Million by the following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and PET Scanners (Includes PET and PET/CT systems). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 31 companies including many key and niche players such as:

- Digirad Corp.
- GE Healthcare Plc
- Mediso Medical Imaging Systems
- Philips Healthcare
- Positron Corporation

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Single-Photon Emission Computed Tomography (SPECT) Systems
SPECT/CT Systems
PET Scanners
PET/CT Systems

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW AND OUTLOOK

Nuclear Medicine Imaging Equipment
A Prelude
Impact of Recession on the Nuclear Medicine Market: In Retrospect
The Road to Recovery
Impact of Healthcare Budget Cuts in Developed Economies: A Review
Positive Outlook for the Healthcare Industry Signals Growth
Table 1: Healthcare Spending as a Percentage of GDP in Select Developed Countries (includes corresponding Graph/Chart)
US
The Dominant Market
Table 2: US Cancer Incidence by Gender: 2014E (includes corresponding Graph/Chart)
Developing Nations Offer Lucrative Opportunities
Table 3: Healthcare Spending as a Percentage of GDP in Select Developing Countries
Lower Share Promising Potential: 2012 (includes corresponding Graph/Chart)
Personalized Medicine Slowly Gaining Ground
Table 4: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart)
Rising Incidence of Cancer
A Major Growth Driver
World Cancer Statistics
Incidence and Mortality Data
Table 5: World Cancer Incidence by Geographic Region (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 6: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 7: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
Table 8: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
Table 9: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
Table 10: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)
Table 11: World Breast Cancer Statistics: Top 20 Countries with Highest Breast Cancer Rates (includes corresponding Graph/Chart)
Cancer Prone Sites based on Age
Table 12: Cancer Incidence in Developed Nations By Site: 2012 (includes corresponding Graph/Chart)
Software Developments Improve Nuclear Medicine Imaging
Competitive Landscape
Competitive Overview in Nuclear Medicine Market
Table 13: Global SPECT Systems (Gamma Cameras) Market by Leading Player (2013): Percentage Market Share Breakdown of Value Sales for GE, Philips, Siemens, and Others (includes corresponding Graph/Chart)
Table 14: Global PET Scanner Market by Leading Player (2013): Percentage Market Share Breakdown of Value Sales for GE, Philips, Siemens, and Others (includes corresponding Graph/Chart)
A Completive Analysis of Major Players in the Nuclear Medicine Market

2. MARKET TRENDS AND ISSUES

Hybrid Imaging to Herald a New Era of Diagnosis
Duration of Hybrid Imaging Procedure Bodes Well for Market
Major Players Come Up with New Hybrid PET/MRI Systems
Broad Clinical Applications to Drive Demand for Hybrid PET/MR Systems
Digital Silicon Photomultiplier Array for PET/MRI Systems
PET-MRI Emerging as a Promising Standard for Imaging Soft Tissue Contrast
Technology Innovations Promise Bright Prospects
Technological Advancements to Drive Growth
Advances in Software
Iterative Reconstruction
Resolution Recovery
Noise Compensation
Hardware Developments
Solid-State Detectors
Innovative Radiopharmaceuticals to Boost Cardiac Applications
Global CVD Stats
Table 15: Global Estimated Fatalities by Heart Conditions
Percentage Share Breakdown for Ischemic Heart Disease, Stroke, CVD, and Others (includes corresponding Graph/Chart)
Table 16: Projected Fatalities in Low Income Countries by Disease (2015 & 2030): Percentage Share Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
Table 17: Projected Fatalities in Mid Income Countries by Disease (2015 & 2030): Percentage Share Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
Table 18: Projected Fatalities in High Income Countries by Disease (2015 & 2030): Percentage Share Breakdown of Number of Deaths for CVD, Cancer, Injury and Others (includes corresponding Graph/Chart)
Table 19: Estimated Annual Medical Cost (US$ Billions) for Coronary Heart Disease (2015, 2020 & 2025) (includes corresponding Graph/Chart)
Battling Alzheimer’s Disease
A Powerful Market Force for Nuclear Medicine
Hypoxia Imaging
The Future of Cancer Therapy
PET or SPECT for Cardiac Imaging
The Debate Continues
Table 20: Worldwide Installed Base of Nuclear Imaging Devices by Modality (2013) Percentage Share Breakdown of Number of Installations for SPECT and PET (includes corresponding Graph/Chart)
Global Nuclear Medicine Market
A Historic Perspective Builder
Table 21: Global Gamma Cameras (SPECT) Market (2006): Installed Base in Units by Select Country
USA, Japan, Canada, and UK (includes corresponding Graph/Chart)
Table 22: Global PET Scanners Market (2006): Installed Base in Units by Select Country
USA, Europe, Japan, Germany, Canada, UK, France, Italy, and Belgium (includes corresponding Graph/Chart)
Innovative Radiotracers
Key to PET & SPECT Success
Innovative Biomarkers to Extend PET in Oncology
Application of PET in Drug Development to Expand Opportunities
SPECT Innovations to Improve Efficiency
Cardiocentric SPECT
Cardio-Focused Collimation
Mobile Devices
Future of Diagnostic Imaging?
Growing Smartphone Sales
A Business Case
Table 23: World Market for Smartphones (2011, 2013 & 2017P): Breakdown of Sales in Thousand Units by Geographic Region/Country (includes corresponding Graph/Chart)
Global Technetium Shortage Eased
Ageing Population
A Vital Demography
Table 24: Global Population Statistics for the 65+ Age Group (Male & Female) for Major Countries/Regions: 2013E (includes corresponding Graph/Chart)
Table 25: Percentage of Population Aged 65 and Above in Europe, US, and Japan (1960-2030) (includes corresponding Graph/Chart)
Table 26: Elderly Population (65+ Years) as a Percentage of the Total Population: 2025 (includes corresponding Graph/Chart)
PET Eats its Way into Conventional Gamma Camera Market
Factors Restricting Market Growth
High Costs
A Major Threat for Market Growth
Supply Shortages: A Niggling Cause of Concern
Canadian Scientists Discover Means to Address Supply Shortages
Price Sensitivity & Competition from Alternatives Limit Market Potential
Unfounded Fears of Radiation Exposure Hinder Growth
Bottlenecks in Developing Markets

3. GLOBAL MEDICAL IMAGING MARKET AN OVERVIEW

Medical Imaging
Changing the Landscape of Clinical Diagnosis
Image-Guided Interventions
Driving Growth in Nuclear Medicine Arena
Understanding the Concept
Tremendous Market Potential
Clinical Application Areas
Diagnostic Imaging Witnesses Dramatic Growth
Table 27: Global Medical Imaging Equipment Installed Base (2013): Percentage Share Breakdown of Volume Installations for X-ray, Ultrasound, Magnetic Resonance, Computed Tomography, and Nuclear Medicine/PET by Country/Region (includes corresponding Graph/Chart)
Comparison of Modalities by Various Imaging Systems
Medical Imaging Equipment Manufacturers Fine Tune Technologies
Future Growth Prospects for Medical Imaging Equipment Market
Multiple Factors Support Global MRI Equipment Market Growth
Reimbursement Remains the Core Issue

4. CANCER A GLOBAL CONCERN

Cancer Incidence
Statistics on New Cases
Cancer Incidence in Developing Countries
Cancer in Asia
Cancer Cases
Mortality Rates

5. NUCLEAR MEDICINE AN INSIGHT

Distinct from General Radiology
History
Major Developments
Nuclear Medicine Scans
Bone Scan
Brain Scan
Gallbladder Scan
Kidney Scan
Liver Scan
Lung Scan
Thyroid Scan
Scrotal Scan
Applications
Cardiac Applications
Neurologic Applications
Oncologic Applications
Orthopedic Applications
Pulmonary Applications
Renal Applications
Other Applications
Table 28: Estimated Time Allocations for Nuclear Medicine Procedures
Radioisotopes: Essential for Nuclear Medicine Procedure
Radioisotopes Used in Medicine
Clinical Applications of Select Isotopes
Radionuclides in Nuclear Medicine Procedures
Table 29: Positron-Emitting Radionuclides in PET Procedures

6. NUCLEAR MEDICINE IMAGING EQUIPMENT

Single-Photon Emission Computed Tomography (SPECT) Systems
SPECT/CT Systems
Positron Emission Tomography (PET) Scanners
Factors Influencing Growth of PET Scanners
PET/CT Systems
PET & Other Imaging Modalities
PET provides the following advantages over other imaging procedures:
Table 30: Comparison of PET and Conventional Imaging Techniques (includes corresponding Graph/Chart)
Brain Imaging
Alzheimer’s Disease
Brain Trauma
Epilepsy
Heart Imaging
Parkinson’s Disease
Cancer
PET-CT: An Advancement in Cancer Diagnosis & Treatment
Mobile PET

7. RESEARCH AND DEVELOPMENT IN THE RECENT PAST

Researchers Develop Portable PET Scanner, SynchroPET
Philips and University Medical Center Hamburg-Eppendorf Develop MRI/PET Imaging Tool
Indian Scientists Develop Low-Cost Nuclear Medicine Kit

8. PRODUCT INNOVATIONS/INTRODUCTIONS

Philips Introduces Vereos Digital PET/CT
Siemens Unveils Biograph mCT Flow
MR Solutions to Unveil Revolutionary 3T, MR/PET Combined Scanner
DDD Obtains FDA Approval for CorCam™
Digirad Introduces Imaging Accessory for Molecular Breast Imaging
GE Unveils Discovery PET/CT 610 and Q. Suite
Agfa Healthcare to Introduce Upgraded Version of IMPAX
GE Secures FDA Clearance for Brivio NM615

9. RECENT INDUSTRY ACTIVITY

AAA Takes Over UK-based Nuclear Medicine Company
BC Technical Inc Acquires NC Systems
BC Technical Acquires Xpert
GE Healthcare Acquires Orbotech Medical Solutions
Comecer Acquires Veenstra Instruments
GE Healthcare Collaborates with NXT2B
Zecotek Inks Development Deal with NuCare
Siemens Healthcare receives FDA Clearance for Biograph mCT PET CT Scanner
GE Healthcare Receives US FDA Clearance for Brivo NM615 Gamma Camera

10. FOCUS ON SELECT GLOBAL PLAYER

Digirad Corp. (US)
GE Healthcare Plc (UK)
Mediso Medical Imaging Systems (Hungary)
Philips Healthcare (US)
Positron Corporation (US)
Siemens Healthcare (Germany)

11. GLOBAL MARKET PERSPECTIVE

Table 31: World Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 32: World Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 33: World 15-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
Nuclear Medicine Imaging Equipment Market by Product Segment
Table 34: World Recent Past, Current & Future Analysis for SPECT Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 35: World Historic Review for SPECT Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 36: World 15-Year Perspective for SPECT Systems by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
Table 37: World Recent Past, Current & Future Analysis for PET Scanners by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 38: World Historic Review for PET Scanners by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 39: World 15-Year Perspective for PET Scanners by Geographic Region
Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A.Market Analysis
Current & Future Analysis
Market Snapshots
Nuclear Medicine Market Drivers and Constraints
Nuclear Medicine Market in the US Rebounds in 2011
Demographic Changes Offer Growth Opportunities
Table 40: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Therapeutic Applications to Drive Growth in the US Nuclear Medicine Market
Market Witnesses Entry of High Value Products
Adoption of SPECT/CT Increasing in the US
PET Procedures in the US Increase
Nuclear Cardiology: Primary Growth Propellant
Dedicated Cardiac PET
The Future of Cardiac Imaging
Personalized Medicine
A Major Driver
Rising Incidence of Cancer
A Major Growth Driver
Table 41: US Cancer Fatalities by Gender (2014): Percentage Share Breakdown of No. of Deaths for Men and Women (includes corresponding Graph/Chart)
Table 42: New Cancer Cases by Gender and Affected Site in the US (2013)
Managing Alzheimer’s Opens New Avenues for PET/SPECT
Alzheimer’s Stats
Table 43: Alzheimer’s Prevalence in the US: As a Percentage of Population by Age-Group (includes corresponding Graph/Chart)
Table 44: Alzheimer’s Prevalence in the US by State: 2014 & 2025 (includes corresponding Graph/Chart)
Expanding Applications of Radiopharmaceuticals to Stimulate Growth
Table 45: Usage of Radiopharmaceutical Agents by Nuclear Medicine Imaging Procedure in the US (2012): Percentage Share Breakdown of Procedure Volume by Type
SPECT and PET (includes corresponding Graph/Chart)
Table 46: US Market for Radiopharmaceuticals Agents by Application (2012): Percentage Share Breakdown of Value Sales for Cardiology and Non-Cardiology Applications (includes corresponding Graph/Chart)
Isotope Shortage Leads to Dependence on Imports
DOE’s Flawed Isotope Program Adds to the Woe
US Fluorodeoxyglucose (FDG) Market
Table 47: US FDG Market by Procedure Type (2012): Percentage Share Breakdown of Procedure Volume for Oncology, Neurology, and Cardiology (includes corresponding Graph/Chart)
Nuclear Medicine Provision Industry Gradually Moves towards Consolidation
Medical Imaging and Nuclear Medicine
Table 48: US Medical Imaging Market by Modality (2013): Percentage Share Breakdown of Revenues for Computed Tomography Imaging, Contrast Agent and Injector, MRI, Nuclear Medicine, Ultrasound Imaging and X-Ray Imaging (includes corresponding Graph/Chart)
Competition
Gamma Cameras
Table 49: US Gamma Camera Market by Leading Players (2013): Percentage Share Breakdown of Value Sales for Digirad Corporation, GE Healthcare, Philips Healthcare, Siemens Healthcare and Others (includes corresponding Graph/Chart)
Table 50: The US Gamma Camera Market in Cardiology Application by Leading Player (2013): Percentage Share Breakdown of Value Sales for Digirad Corporation, GE Healthcare, Philips Healthcare and Siemens Healthcare (includes corresponding Graph/Chart)
PET Scanners
Table 51: US PET Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for GE Healthcare, Philips Healthcare, Siemens Healthcare and Others (includes corresponding Graph/Chart)
Regulatory Overview
Nuclear Regulatory Commission (NRC)
Food and Drug Administration (FDA)
Environmental Protection Agency (EPA)
Centers for Medicare & Medicaid Services (CMS)
Overview of Medicare Reimbursements
Medicare Payment Settings for Contrast Agents and Radiopharmaceuticals
Medicare Coverage
Product Launches
Strategic Corporate Development
Select Key Players
B.Market Analytics
Table 52: The US Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems (with Single Head Gamma Cameras, Dual Head Gamma Cameras, and Triple Head Gamma Cameras) and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 53: The US Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems (with Single Head Gamma Cameras, Dual Head Gamma Cameras, and Triple Head Gamma Cameras) and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 54: The US 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems (with Single Head Gamma Cameras, Dual Head Gamma Cameras, and Triple Head Gamma Cameras) and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

2. CANADA

A.Market Analysis
Current & Future Analysis
Canada Faces Paucity of PET Scanners
PET Imaging for Cancer
A Long Way to Go
Canadian Scientists Discover Remedy for Isotope Shortages
An Overview of Medical Imaging Market
Regulatory and Legal Restrictions
Product Launch
B.Market Analytics
Table 55: Canadian Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 56: Canadian Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 57: Canadian 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

3. JAPAN

A.Market Analysis
Japanese Healthcare System: An Overview
Fast Facts
Demographics Drive Market Growth
Table 58: Japanese Population by Age Group (2012) (includes corresponding Graph/Chart)
Table 59: Japanese 65+ Years Population: 1950-2010 (includes corresponding Graph/Chart)
Market Scenario
Table 60: PET Studies Performed in Japan (2008): Percentage Breakdown by Type
Tumor, Brain, Heart, and Others (includes corresponding Graph/Chart)
Production and Exports of Nuclear medicine imaging equipment Suffer in Japan
Reimbursement Issues
Government Initiatives
B.Market Analytics
Table 61: Japanese Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 62: Japanese Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 63: Japanese 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

4. EUROPE

A.Market Analysis
Debt Crisis in Europe Affects Healthcare Industry
European Healthcare System: In a State of Transition?
Table 64: European Installed Base for Diagnostic Imaging Equipment by Modality (2013): Percentage Share Breakdown of Volume Installations for SPECT, PET/CT, SPECT/CT, Planar, Cardiac SPECT, and PET/MR (includes corresponding Graph/Chart)
Oncology Dominates Nuclear Medicine Procedure
Table 65: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 66: European Nuclear Medicine Market by Therapeutic Area: Percentage Share Breakdown of Imaging Volume for Oncology, Cardiac, Endocrine, Lung, Renal, Brain and Infection (includes corresponding Graph/Chart)
Ageing Demography
An Opportunity Indicator
Table 67: Population Breakup by Age Group for Select European Countries: 2011 (as a Percentage of Total Population) (includes corresponding Graph/Chart)
B.Market Analytics
Table 68: European Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 69: European Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 70: European 15-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region
Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
Table 71: European Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 72: European Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 73: European 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
Market Analysis
Table 74: French Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 75: French Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 76: French 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
Market Analysis
Table 77: German Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 78: German Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 79: German 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Current & Future Analysis
Product Launch
B.Market Analytics
Table 80: Italian Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 81: Italian Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 82: Italian 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
Ge Healthcare Plc
A Key Player in The Uk
B.Market Analytics
Table 83: The UK Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 84: The UK Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 85: The UK 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analysis
Table 86: Spanish Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 87: Spanish Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 88: Spanish 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 89: Russian Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 90: Russian Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 91: Russian 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Current & Future Analysis
Mediso Medical Imaging Systems (Hungary)
A Key Player
Strategic Corporate Development
B.Market Analytics
Table 92: Rest of European Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 93: Rest of Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 94: Rest of Europe 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A.Market Analysis
Current & Future Analysis
Burden of Chronic Diseases in Aging Populace
Potential Opportunities for Nuclear Medicine
Table 95: Over 65 Years Individuals as % of Total Population in Select Asian Countries (includes corresponding Graph/Chart)
India & China Offer Significant Growth Opportunities
Table 96: China and India Leads Global Population (July 2013):Table Depicting China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart)
Table 97: Age-wise Breakup of China and India’s Population Vis-à-vis Other Populous Countries Globally: As of July 2013 (includes corresponding Graph/Chart)
B.Market Analytics
Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 99: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 100: Asia-Pacific 15-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region
Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 102: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 103: Asia-Pacific 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Current & Future Analysis
Medical Imaging Device Market
An Overview
Increasing Expenditure on Healthcare Sector
B.Market Analytics
Table 104: Chinese Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 105: Chinese Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 106: Chinese 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
5b. INDIA
A.Market Analysis
Current & Future Analysis
Table 107: Installed Base of Nuclear Medicine Scanners in India in 2011 (includes corresponding Graph/Chart)
India Offers High Growth Potential
Regulatory Mechanism for Guiding Isotope Production and Distribution
PET/CT Scanning in India Gathers Momentum
Overview of CT Scanners Market in India
Developments in Clinical Practice and Technology
Product Launch
B.Market Analytics
Table 108: Indian Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 109: Indian Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 110: Indian 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Korea
Strategic Corporate Development
B.Market Analytics
Table 111: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 112: Rest of Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 113: Rest of Asia-Pacific 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 114: Latin American Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 115: Latin American Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 116: Latin American 15-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region
Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
Table 117: Latin American Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 118: Latin American Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 119: Latin American 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
6a. BRAZIL
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 120: Brazilian Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 121: Brazilian Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 122: Brazilian 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)
6b. REST OF LATIN AMERICA
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 123: Rest of Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 124: Rest of Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 125: Rest of Latin America 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 126: Rest of World Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 127: Rest of World Historic Review for Nuclear Medicine Imaging Equipment by Product Segment
SPECT Systems and PET Scanners Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 128: Rest of World 15-Year Perspective for Nuclear Medicine Imaging Equipment by Product Segment
Percentage Breakdown of Value Sales for SPECT Systems and PET Scanners Markets for Years 2006, 2014, & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 31 (including Divisions/Subsidiaries 35)
The United States (18) Canada (2) Japan (2) Europe (9)
Germany (2)
The United Kingdom (2)
Italy (2)
Rest of Europe (3) Asia-Pacific (Excluding Japan) (4)

Question What is the base year for the data included?
Answer 2011 is the base year for the data included in this report.
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos